Additionally, the surge in telehealth services and digital therapeutics applications is facilitating better patient engagement and adherence to treatment regimens. The supergenerics segment is expected to grow substantially in the coming years due toits innovative approach to drug formulation. These formulations consist of newand improved ones with better delivery mechanisms and increased efficacy. Theyare widely used by doctors and other healthcare providers looking for slightlyhigher-budget treatment options. Pharmaceutical companies also see growingdemand for these super generics, leading to investment and ramping productioncapabilities. As patient demand for enhanced therapies rises, the supergenerics segment is expected to grow significantly.
Prescription Drugs Market Regional Analysis
This has previously been referred to as the ‘Iron Law of Prohibition’, whereby pressures due to attempted interruption and suppression of the illicit drug supply leads to ever-more compact substitutes 46. Following China’s announcement to control fentanyl in 2019, several local drug laboratories emerged in Mexico and other North American metropolitan areas 30. Concurrently, Mexican methamphetamine imports increased, making the product a cheap and successful competitor to locally produced methamphetamine. According to police reports this resulted in pre-existing Canadian labs shifting their focus towards fentanyl production as well. The Australian police has recently seized a large shipment of fentanyl and methamphetamine from Canada, indicating that the upscale in North America’s local drug production has already resulted in the area becoming a net exporter of drugs 47. It is possible that the trend of local production of ultrapotent opioids in small laboratories, as currently observed in BC, will spread out to other urban areas in the US, making imports of these substances entirely obsolete.
Anti-Obesity Drugs Market Analysis
- The current trend towards the use of high potent synthetic opioids, especially fentanyl, has caused an extreme increase in the prevalence of non-fatal and fatal overdose events 13, 14.
- If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us Media.
- This growth is expected to continue during the forecast period, owing to the launch of various pipeline candidates for various indications by key players.
- With growing disposable income, especially among the middle class, people can afford highly expensive drugs.
- The rising prevalence of chronic diseases, the growing senior population, and rising healthcare costs are all factors contributing to this trend.
Latin America pharmaceutical market is witnessing growth in the pharmaceutical market, supported by increasing healthcare expenditure and rising awareness of advanced treatment options. Brazil is the key market, driven by government health initiatives and investments in local biopharmaceutical manufacturing. The rising prevalence of chronic and infectious diseases is fostering demand for effective therapies. Hospital pharmacies dominate distribution, while retail pharmacies are expanding their presence. Biologics and biosimilars (large molecules) is projected to grow at a significant CAGR over the forecast period due to their effectiveness in treating chronic and complex diseases such as cancer, autoimmune disorders, and diabetes.
The development of public awareness about obesity and its health impact through the social media platform, will encourage more individuals to seek the treatment, enabling market players to strengthen their position in this growing sector. Generic drugs are off-patent drugs that are bioequivalent to the original drug in terms of dosage, strength, quality, form, efficacy, intended use, side effects, and route of administration. In the United States, there has been a significant increase in the production of generic drugs, which are cheaper than the original drugs and do not require extensive research and testing. In addition, the introduction of generic drugs has improved patient access and saved taxpayers, employers, and insurers, sustaining the nation’s healthcare system.
Patients preferred pills over injection forms, and pharmacies stocked more oral generics than injections. Much as a ubiquitous police presence has had little impact on the drug market, ubiquitous health services have done little to stem the tide of overdoses. Research suggests that, while needle-exchange programs may limit the spread of HIV, they do not reduce overdose deaths—and may actually increase them. Insofar as harm-reduction services mitigate the risks of drug use, they make using in places where they are available more attractive than using in places where they are not available. The city’s commitment to harm reduction, in other words, is a perk of shopping in Kensington—a publicly funded benefit for drug users.
However, the resurgence of routine healthcare services after the initial COVID-19 shutdown and patient visits to healthcare centers increased globally. Moreover, rising R&D initiatives for the development and launch of COVID-19 treatment drugs by major players surged the demand for vaccines and orphan drugs among the population. Moreover, the high emphasis on shifts to homecare settings by patients, along with uptake in the use of biosimilar, a large pipeline of new increased approvals of specialty medications by regulatory authorities, further propelled the drug’s adoption. The branded drugs segment dominated the market with the largest revenue share of 62.5% in 2024, attributed to patent exclusivity, strong marketing strategies, and clinical preference in specialty therapeutics. The prescription drugs segment is expected to capture 65.2% share in 2025, reflecting the critical role these drugs play in managing a wide spectrum of health conditions.
Market Share By Geographical Regions
Artificial Intelligence assists manufacturers in the generic medicines industry to accelerate development and guarantee quality. Together with machine-learning technologies, AI and machine-learning systems can predict how a drug acts in the body and suggest excipients to use, thereby avoiding lab trials and increasing precision and accuracy in formulation. In 2018, the city and state launched the Kensington Initiative, which focused on identifying, arresting, and incarcerating about 100 higher-ups in the Kensington market, hoping to cripple the drug-running infrastructure. One, from a team at Temple University, found a statistically significant reduction in adult loitering and signs of drug selling.
Pipeline Analysis: Close To 120 Anti-Obesity Programs Are In Clinical Trials
The Indian pharmaceutical sector is ranked third globally in terms of volume and fourteenth globally in terms of value, according to Invest India, an agency of the Indian Government for Investment Promotion and Facilitation. Along with having more than 3,000 pharmaceutical businesses and more than 10,500 production facilities, India also has the most US-FDA compliant pharmaceutical plants outside of the United States. In addition, the prevalence of psoriasis in the world varies from 0.09 percent to 11.43%, making it a serious condition that affects at least 100 million people worldwide. The fact is that topical drug administration is the primary therapy method for most skin conditions, and the market for advanced topical products is projected to grow in the upcoming years.
Anti-Obesity Drugs Market Segmentation Insights
Super generics are expected to grow with the fastest CAGR in the generic drugs market because they are a better version of expired-brand medicines at significantly lower prices. They have better delivery, longer-lasting effects, so people tend to choose them over any other brand options. According to forecasts, the global antipsychotic drugs market will grow from USD 19.45 billion in 2024 to USD 41.21 billion by 2034, with an expected CAGR of 7.8%. Antipsychotic drugs help manage symptoms of mental health conditions like schizophrenia and bipolar disorder.
That number could rise to 30 million in 2035, or about 20% to 25% of the obese population, a potential market of $80 billion. The adoption of weight-loss drugs is likely to accelerate in a pattern similar to structural changes in the technology cycle, such as the introduction of smartphones. Patients’ use will increase as they become more familiar and comfortable with the new products and as manufacturers address hurdles in production, distribution and regulatory issues. Pfizer makes more than 313 drugs in the U.S., including the blood thinner Eliquis, which they share with Bristol Myers Squibb, Ibrance, a cancer drug, and the 2025 COVID vaccine.
Market Size & Forecast
There are lessons to be learned from European countries like Switzerland and the Netherlands. These countries broke with established paradigms and successfully tackled the heroin- and HIV-crisis of the 1990s by implementing heroin-assisted treatment as a novel and effective treatment regimen 57. To this day, strategies that directly address the issue of treatment attractiveness like intranasal heroin-assisted treatment and extended take-home doses are actively being investigated and early results are promising 58–61. These strategies to improve treatment attractiveness are needed in North America and novel approaches like fentanyl-assisted treatment have already been proposed but are far from being evaluated and implemented 62. The prevalence of stimulant use is increasing, and novel synthetic stimulants enter the market each year.
- Samruddhi Yardi has done her MBA in Marketing, and after working in sales for 4+ years, she has shifted to the market research industry.
- Increasing organ transplant procedures is also anticipated to drive the growth of the immunosuppressants segments.
- Inhalable generics, though embryonic, project a 9.89% CAGR through 2030 as global respiratory disease incidence escalates.
- Based on the drug delivery, the US generic drug market can be bifurcated into oral, injectables, dermal/topical, and inhalers.
- The center still operates today, offering a variety of harm-reduction services; many users in Kensington carry gray cards, notifying police that their needles came from Prevention Point.
Companies commissioning modular plants on EU soil may gain accelerated assessment timelines, effectively translating capital expenditure into earlier revenue realisation. Cardiovascular therapies retained 22.50% of 2024 revenue on the back of entrenched prescription volumes for antihypertensives, statins, and antithrombotics. Long-cycle consumption fosters predictable demand curves, enabling manufacturers to fine-tune capacity allocation. Branded reference price erosion remains gradual, allowing disciplined generic price management that stabilizes gross margins despite competitive density. Germany and Italy reported the highest proportion of positive ratings for both orphan drugs and non-orphan drugs. In contrast, Spain had the fewest HTA evaluations for orphan drugs and the second fewest for non-orphan drugs with a mixture of outcomes.
Adverse Effects Of Antipsychotic Drugs Causing Hurdles To Market Growth
The growing availability of prescription drugs and the rising need for daily medications, such as anti-diabetics, are some of the major factors responsible for the growth of this segment over the forecast period. The U.S. OTC drugs industry is fragmented in nature, with the presence of both leading global players as well as local and regional players. The top 5 players, such as Haleon, Kenvue, Bayer, Procter & Gamble Company, and Reckitt, hold 18.4% of the U.S. market share.
Rising Cases Of Chronic Diseases Boosts Market Demand
The over-the-counter pharmaceuticals sector covers a range of non-prescription medications, treatments, and healthcare items that consumers can buy directly without the need for a prescription from a licensed healthcare provider. Europe is observed to grow at a considerable rate in the upcoming period in the anti-obesity drugs market. It is stemming from higher obesity rates, supportive healthcare policies with strong health infrastructure, and an increasing demand for weight loss treatments. Also, the World Health Organization reports that a significant portion of adults and children in the WHO European Region are overweight or obese.
Overall, the proper prescription and utilization of these medications remain critical in promoting better health outcomes and well-being for individuals worldwide. At Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us Media. We appreciate your support and look forward to continuing to provide valuable insights for our audience. The total prescription drug spending by the U.S. in 2022 was higher than other developed countries such as Australia (13.9 billion) and the U.K.
These are an exactcopy of branded drugs with the same dosage, active ingredients, andeffectiveness, making them a cost-effective option for patients and healthcareproviders in emerging economies, especially in Asia. Governments and insurancecompanies actively promote simple generics as part of cost-cutting measures inhealthcare expenditure. Additionally, the continuous expiration of patents onblockbuster drugs fuels the introduction of new simple generics, ensuring asteady market supply. The number of branded pharmaceuticals whose patents are about to expire is steadily increasing, creating enormous potential opportunities in the drug market.
